Now livetag icon
2026 State of Ecommerce: Own the AI Shopper Journey.Download Reportbanner icon
Camurus

August 2026

Camurus Market Share Analysis for August 2026

Camurus is a Swedish science-led biopharmaceutical company committed to improving the lives of patients with severe and chronic diseases.
Year Founded1991
Employees201 - 500
Annual Revenue$200M - $500M
camurus.com
Camurus
Camurus (including company regionals)
  • camurus.com
    camurus.com
See more website traffic and engagement information

Camurus Revenue up to August 2026 is 200M - 500M

revenue generated by Camurus top domains

Camurus top domains revenue over 3 years

Revenue for Camurus top domains

camurus.comcamurus.com200M - 500M
See more with Sales Intelligence

Total visits to Camurus's top domains

Understand Camurus market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Camurus's top domains

Analyze Camurus engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Camurus's top domains

See how Camurus keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Camurus

These are the website technologies, by industry, used by Camurus top domains

Audio Video Media (3)

Vimeo

Vimeo

Social (3)

Instagram

Instagram

Advertising (2)

DoubleClick

DoubleClick

Content Management System (2)

WordPress

WordPress

More Technologies

10

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Camurus

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCamurus AB is developing long-acting incretin-based therapies for cardiometabolic diseases on Jun 2nd '26.Camurus has entered a global collaboration and license agreement with Eli Lilly and Company to develop long-acting incretin-based therapies for cardiometabolic diseases using its FluidCrystal technology platform.
NewsCamurus AB will attend event Jefferies Global Healthcare Conference on Jun 3rd '26.Camurus to present at Jefferies Global Healthcare Conference.
NewsCamurus AB attended event Lund Grand Prix on Apr 22nd '26.Camurus has been awarded Lund Municipality's Business Award 2025 at the Lund Grand Prix, held on April 22 at The Loop in Science Village, Lund, Sweden.

See all Camurus signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.